Hims & Hers Health, Inc. announced that its subsidiaries have entered into a Master Receivables Purchase Agreement (RPA) with JPMorgan Chase Bank, N.A. The agreement establishes a facility allowing the company to sell certain eligible receivables for cash, providing up to $400 million in financing capacity.
Key Details
- Agreement: Subsidiaries XeCare LLC and Apostrophe Pharmacy LLC entered into the RPA with JPMorgan Chase Bank on July 1, 2026, which includes a facility limit of $400,000,000 for the purchase of eligible receivables.
- Terms: The RPA has an initial term of 364 days, with options for extension. Hims & Hers Health, Inc. has provided a performance guarantee for its subsidiaries' obligations under the agreement.
- Credit Agreement Amendment: On June 26, 2026, the company amended its existing Revolving Credit and Guaranty Agreement to permit the transactions contemplated by the new receivables purchase facility.